AI in healthcare: the expert Arnaud Lambert gives his analysis of companies in the Altaroc Vintages

Arnaud describes Eye Screening as a company at the intersection of healthcare and artificial intelligence, specializing in the development of diagnostic support tools for ophthalmology and dermatology. The goal is to integrate these technologies into comprehensive care pathways to help healthcare professionals become more efficient and better meet the growing needs of patients.Artificial intelligence appears to be a key solution to the structural challenges facing the healthcare system: a shortage of doctors, an aging population, and an increase in chronic diseases. It helps improve diagnostic accuracy, optimize medical processes, and make care more accessible. However, these tools remain at the service of doctors and do not replace their expertise. An analysis of the sector highlights three major categories of innovation in healthcare. The first concerns diagnostic support tools, which provide complementary expertise in fields such as cardiology, fertility, and medical imaging. The second encompasses operational optimization solutions, aimed at streamlining care pathways and improving professional efficiency. Finally, the third category concerns the discovery of new therapies, with medicine becoming increasingly personalized and predictive.These technologies are considered revolutionary in that they increase the healthcare system’s capacity and provide solutions to problems that have been difficult to address until now. They also open up significant opportunities, particularly in fields such as in vitro fertilization, where AI could significantly improve success rates.The healthcare sector, combined with technology, is characterized by strong growth, resilience, and low cyclicality. It thus represents a particularly attractive arena for innovation and investment, with a direct impact on people’s quality of life.